Spero Therapeutics Inc (NASDAQ:SPRO)

12.10
Delayed Data
As of May 18
 -0.04 / -0.33%
Today’s Change
9.66
Today|||52-Week Range
19.00
+2.98%
Year-to-Date

Stock Price Forecast

The 5 analysts offering 12-month price forecasts for Spero Therapeutics Inc have a median target of 27.00, with a high estimate of 30.00 and a low estimate of 16.00. The median estimate represents a +123.14% increase from the last price of 12.10.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Buy stock in Spero Therapeutics Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.97
Sales
$200.0K
Reporting Date
Aug 29

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -31.35%
 
 
 
 
 
 
Growthannually 81.45%
 
 
 

Sales

Growthquarterly -82.65%
 
 
 
 
 
 
Growthannually 113.61%
 
 
 
Key to the earnings and sales forecast charts.